Replies to post #312 on Crispr Therapeutics AG (CRSP)

[jondoeuk]

A CRISPR spokesperson told Endpoints that the company is striving to restore AAT levels toward ''the normal range (>20 µM),'' while others have set the goal of partially restoring AAT levels in the blood to a level of 11 µM. Also that CRISPR is discussing a potential licensing deal with Prime Medicine. https://endpoints.news/crispr-therapeutics-says-its-new-gene-editing-tool-is-a-significant-advance-over-prime-editing-prime-medicine-disagrees/